Functional inhibition of CCR3‐dependent responses by peptides derived from phage libraries
暂无分享,去创建一个
[1] M. Baggiolini,et al. The Ligands of CXC Chemokine Receptor 3, I-TAC, Mig, and IP10, Are Natural Antagonists for CCR3* , 2001, The Journal of Biological Chemistry.
[2] H. Sarau,et al. Identification of Potent, Selective Non-peptide CC Chemokine Receptor-3 Antagonist That Inhibits Eotaxin-, Eotaxin-2-, and Monocyte Chemotactic Protein-4-induced Eosinophil Migration* , 2000, The Journal of Biological Chemistry.
[3] E. Fernandez,et al. Comparison of the structure of vMIP-II with eotaxin-1, RANTES, and MCP-3 suggests a unique mechanism for CCR3 activation. , 2000, Biochemistry.
[4] M. Stone,et al. Characterization of binding between the chemokine eotaxin and peptides derived from the chemokine receptor CCR3. , 2000, The Journal of biological chemistry.
[5] M. Peck,et al. A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3 , 2000, The Journal of Biological Chemistry.
[6] M. Manns,et al. Allergy and the Gut , 2000, International Archives of Allergy and Immunology.
[7] M. Horwitz,et al. Regulation of the NF-κB Activation Pathway by Isolated Domains of FIP3/IKKγ, a Component of the IκB-α Kinase Complex* , 2000, The Journal of Biological Chemistry.
[8] A. Balic,et al. Do eosinophils have a role in the killing of helminth parasites? , 2000, Parasitology today.
[9] B. Nardelli,et al. C-C Chemokine Receptor 3 Antagonism by the β-Chemokine Macrophage Inflammatory Protein 4, a Property Strongly Enhanced by an Amino-Terminal Alanine-Methionine Swap1 , 2000, The Journal of Immunology.
[10] M. Humbert,et al. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics. , 1999, Journal of immunology.
[11] F. Annunziato,et al. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. , 1999, The American journal of pathology.
[12] J. Mach,et al. New inhibitors of Helicobacter pylori urease holoenzyme selected from phage-displayed peptide libraries. , 1999, European journal of biochemistry.
[13] S. Bel,et al. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. , 1999, Journal of immunology.
[14] Durham,et al. The inflammatory nature of allergic disease , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[15] S. Durham. Mechanisms of mucosal inflammation in the nose and lungs. , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[16] C. Mackay,et al. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils , 1997, Current Biology.
[17] M. Baggiolini,et al. Blocking Chemokine Receptors , 1997, The Journal of experimental medicine.
[18] C. Mackay,et al. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. , 1997, Science.
[19] C. Mackay,et al. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. , 1997, The Journal of clinical investigation.
[20] N. Skelton,et al. Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3 and CCR5. , 1997, Biochemistry.
[21] T. Schwartz,et al. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. , 1997, Science.
[22] P. Leder,et al. Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia , 1997, The Journal of experimental medicine.
[23] C. Mackay,et al. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. , 1997, The Journal of clinical investigation.
[24] Simon A. Jones,et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes , 1996, The Journal of experimental medicine.
[25] Ronald W. Barrett,et al. Small Peptides as Potent Mimetics of the Protein Hormone Erythropoietin , 1996, Science.
[26] J. H. Butler,et al. High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] M. Montjovent,et al. Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent Antagonist (*) , 1996, The Journal of Biological Chemistry.
[28] S. Miller,et al. Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neutrophils , 1995, The Journal of cell biology.
[29] L. Lichtenstein,et al. Blood and bronchoalveolar eosinophils in allergic subjects after segmental antigen challenge: surface phenotype, density heterogeneity, and prostanoid production. , 1994, The Journal of allergy and clinical immunology.
[30] W. DeGrado,et al. Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library , 1992, Proteins.
[31] R. Aebersold,et al. Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide. , 1991, Biochemistry.
[32] J. Scott,et al. Searching for peptide ligands with an epitope library. , 1990, Science.
[33] M. Baggiolini,et al. Ion channels in human neutrophils activated by a rise in free cytosolic calcium concentration , 1986, Nature.